nodes	percent_of_prediction	percent_of_DWPC	metapath
Magnesium salicylate—PTGS2—Risedronate—osteoporosis	0.416	0.597	CbGbCtD
Magnesium salicylate—ALB—Estropipate—osteoporosis	0.199	0.285	CbGbCtD
Magnesium salicylate—ALB—Estradiol—osteoporosis	0.0826	0.118	CbGbCtD
Magnesium salicylate—PTGS2—Synthesis of 15-eicosatetraenoic acid derivatives—GPX1—osteoporosis	0.00177	0.0413	CbGpPWpGaD
Magnesium salicylate—PTGS1—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.00164	0.0384	CbGpPWpGaD
Magnesium salicylate—PTGS2—Prostaglandin Synthesis and Regulation—ANXA2—osteoporosis	0.00131	0.0305	CbGpPWpGaD
Magnesium salicylate—Erythema multiforme—Etidronic acid—osteoporosis	0.00115	0.00443	CcSEcCtD
Magnesium salicylate—Decreased appetite—Calcium Acetate—osteoporosis	0.00114	0.0044	CcSEcCtD
Magnesium salicylate—Pain—Calcium Acetate—osteoporosis	0.00112	0.00433	CcSEcCtD
Magnesium salicylate—Constipation—Calcium Acetate—osteoporosis	0.00112	0.00433	CcSEcCtD
Magnesium salicylate—Anorexia—Ergocalciferol—osteoporosis	0.00111	0.00426	CcSEcCtD
Magnesium salicylate—Drowsiness—Calcitriol—osteoporosis	0.0011	0.00423	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Risedronate—osteoporosis	0.0011	0.00422	CcSEcCtD
Magnesium salicylate—Sweating—Raloxifene—osteoporosis	0.00109	0.00419	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Calcium Acetate—osteoporosis	0.00108	0.00417	CcSEcCtD
Magnesium salicylate—Sweating—Ibandronate—osteoporosis	0.00108	0.00415	CcSEcCtD
Magnesium salicylate—Lethargy—Zoledronate—osteoporosis	0.00106	0.0041	CcSEcCtD
Magnesium salicylate—Erythema—Etidronic acid—osteoporosis	0.00106	0.00407	CcSEcCtD
Magnesium salicylate—Skin exfoliation—Estradiol—osteoporosis	0.00106	0.00407	CcSEcCtD
Magnesium salicylate—Asthma—Risedronate—osteoporosis	0.00104	0.004	CcSEcCtD
Magnesium salicylate—Decreased appetite—Ergocalciferol—osteoporosis	0.00101	0.00389	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—PRDX3—osteoporosis	0.001	0.0234	CbGpPWpGaD
Magnesium salicylate—Abdominal discomfort—Risedronate—osteoporosis	0.000994	0.00383	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Estropipate—osteoporosis	0.000993	0.00383	CcSEcCtD
Magnesium salicylate—Constipation—Ergocalciferol—osteoporosis	0.000992	0.00383	CcSEcCtD
Magnesium salicylate—Pain—Ergocalciferol—osteoporosis	0.000992	0.00383	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Alendronate—osteoporosis	0.000978	0.00377	CcSEcCtD
Magnesium salicylate—Weight increased—Ethinyl Estradiol—osteoporosis	0.000968	0.00373	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Zoledronate—osteoporosis	0.000951	0.00367	CcSEcCtD
Magnesium salicylate—Flushing—Raloxifene—osteoporosis	0.000944	0.00364	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Calcitriol—osteoporosis	0.000932	0.00359	CcSEcCtD
Magnesium salicylate—PTGS2—Calcium signaling in the CD4+ TCR pathway—NFATC1—osteoporosis	0.00093	0.0217	CbGpPWpGaD
Magnesium salicylate—Pruritus—Calcium Acetate—osteoporosis	0.000929	0.00358	CcSEcCtD
Magnesium salicylate—Erythema—Estropipate—osteoporosis	0.000914	0.00352	CcSEcCtD
Magnesium salicylate—Erythema—Alendronate—osteoporosis	0.0009	0.00347	CcSEcCtD
Magnesium salicylate—Asthma—Zoledronate—osteoporosis	0.0009	0.00347	CcSEcCtD
Magnesium salicylate—Diarrhoea—Calcium Acetate—osteoporosis	0.000899	0.00347	CcSEcCtD
Magnesium salicylate—Deafness—Estradiol—osteoporosis	0.000897	0.00346	CcSEcCtD
Magnesium salicylate—Dysgeusia—Alendronate—osteoporosis	0.000882	0.0034	CcSEcCtD
Magnesium salicylate—Erythema—Ibandronate—osteoporosis	0.000877	0.00338	CcSEcCtD
Magnesium salicylate—Confusional state—Etidronic acid—osteoporosis	0.00087	0.00335	CcSEcCtD
Magnesium salicylate—Dizziness—Calcium Acetate—osteoporosis	0.000869	0.00335	CcSEcCtD
Magnesium salicylate—Asthma—Conjugated Estrogens—osteoporosis	0.000867	0.00334	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Zoledronate—osteoporosis	0.000863	0.00333	CcSEcCtD
Magnesium salicylate—Dysgeusia—Ibandronate—osteoporosis	0.000859	0.00331	CcSEcCtD
Magnesium salicylate—Erythema—Calcitriol—osteoporosis	0.000858	0.00331	CcSEcCtD
Magnesium salicylate—Dysgeusia—Calcitriol—osteoporosis	0.00084	0.00324	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—WDR1—osteoporosis	0.000839	0.0196	CbGpPWpGaD
Magnesium salicylate—Vomiting—Calcium Acetate—osteoporosis	0.000835	0.00322	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Conjugated Estrogens—osteoporosis	0.000831	0.0032	CcSEcCtD
Magnesium salicylate—Weight increased—Zoledronate—osteoporosis	0.000819	0.00316	CcSEcCtD
Magnesium salicylate—Lethargy—Estradiol—osteoporosis	0.000819	0.00316	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.000805	0.0031	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—WDR1—osteoporosis	0.0008	0.0186	CbGpPWpGaD
Magnesium salicylate—ALB—Bile acid and bile salt metabolism—CYP27A1—osteoporosis	0.000798	0.0186	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000796	0.0186	CbGpPWpGaD
Magnesium salicylate—Weight increased—Conjugated Estrogens—osteoporosis	0.000789	0.00304	CcSEcCtD
Magnesium salicylate—ALB—Lipoprotein metabolism—P4HB—osteoporosis	0.000785	0.0183	CbGpPWpGaD
Magnesium salicylate—Nausea—Calcium Acetate—osteoporosis	0.00078	0.00301	CcSEcCtD
Magnesium salicylate—Tinnitus—Risedronate—osteoporosis	0.000774	0.00298	CcSEcCtD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—MGLL—osteoporosis	0.000768	0.0179	CbGpPWpGaD
Magnesium salicylate—Dyspepsia—Etidronic acid—osteoporosis	0.000759	0.00293	CcSEcCtD
Magnesium salicylate—Oedema—Estropipate—osteoporosis	0.000746	0.00288	CcSEcCtD
Magnesium salicylate—Constipation—Etidronic acid—osteoporosis	0.000738	0.00284	CcSEcCtD
Magnesium salicylate—Abdominal pain upper—Estradiol—osteoporosis	0.000733	0.00283	CcSEcCtD
Magnesium salicylate—Flushing—Pamidronate—osteoporosis	0.000732	0.00282	CcSEcCtD
Magnesium salicylate—Shock—Raloxifene—osteoporosis	0.000711	0.00274	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Etidronic acid—osteoporosis	0.000711	0.00274	CcSEcCtD
Magnesium salicylate—Shock—Ibandronate—osteoporosis	0.000704	0.00271	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Raloxifene—osteoporosis	0.000699	0.00269	CcSEcCtD
Magnesium salicylate—Asthma—Estradiol—osteoporosis	0.000694	0.00268	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Ibandronate—osteoporosis	0.000692	0.00267	CcSEcCtD
Magnesium salicylate—Nausea—Ergocalciferol—osteoporosis	0.000689	0.00266	CcSEcCtD
Magnesium salicylate—Erythema—Pamidronate—osteoporosis	0.000687	0.00265	CcSEcCtD
Magnesium salicylate—Urticaria—Etidronic acid—osteoporosis	0.000685	0.00264	CcSEcCtD
Magnesium salicylate—Dysgeusia—Pamidronate—osteoporosis	0.000673	0.00259	CcSEcCtD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	0.000669	0.0156	CbGpPWpGaD
Magnesium salicylate—Flushing—Zoledronate—osteoporosis	0.000669	0.00258	CcSEcCtD
Magnesium salicylate—Anorexia—Calcitriol—osteoporosis	0.000668	0.00257	CcSEcCtD
Magnesium salicylate—Abdominal discomfort—Estradiol—osteoporosis	0.000665	0.00256	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—CAP1—osteoporosis	0.000663	0.0155	CbGpPWpGaD
Magnesium salicylate—Somnolence—Estropipate—osteoporosis	0.000663	0.00256	CcSEcCtD
Magnesium salicylate—Dyspepsia—Estropipate—osteoporosis	0.000657	0.00253	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.000656	0.00253	CcSEcCtD
Magnesium salicylate—Dyspepsia—Alendronate—osteoporosis	0.000647	0.00249	CcSEcCtD
Magnesium salicylate—ALB—Selenium Micronutrient Network—PRDX3—osteoporosis	0.000644	0.015	CbGpPWpGaD
Magnesium salicylate—Constipation—Estropipate—osteoporosis	0.000638	0.00246	CcSEcCtD
Magnesium salicylate—Pain—Estropipate—osteoporosis	0.000638	0.00246	CcSEcCtD
Magnesium salicylate—Dyspepsia—Raloxifene—osteoporosis	0.000636	0.00245	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—CAP1—osteoporosis	0.000632	0.0147	CbGpPWpGaD
Magnesium salicylate—Weight increased—Estradiol—osteoporosis	0.000631	0.00243	CcSEcCtD
Magnesium salicylate—Dyspepsia—Ibandronate—osteoporosis	0.00063	0.00243	CcSEcCtD
Magnesium salicylate—Constipation—Alendronate—osteoporosis	0.000628	0.00242	CcSEcCtD
Magnesium salicylate—Pain—Alendronate—osteoporosis	0.000628	0.00242	CcSEcCtD
Magnesium salicylate—Erythema—Zoledronate—osteoporosis	0.000627	0.00242	CcSEcCtD
Magnesium salicylate—Somnolence—Calcitriol—osteoporosis	0.000623	0.0024	CcSEcCtD
Magnesium salicylate—Decreased appetite—Ibandronate—osteoporosis	0.000622	0.0024	CcSEcCtD
Magnesium salicylate—Pain—Raloxifene—osteoporosis	0.000618	0.00238	CcSEcCtD
Magnesium salicylate—Dysgeusia—Zoledronate—osteoporosis	0.000614	0.00237	CcSEcCtD
Magnesium salicylate—Pain—Ibandronate—osteoporosis	0.000612	0.00236	CcSEcCtD
Magnesium salicylate—Constipation—Ibandronate—osteoporosis	0.000612	0.00236	CcSEcCtD
Magnesium salicylate—Pruritus—Etidronic acid—osteoporosis	0.00061	0.00235	CcSEcCtD
Magnesium salicylate—Decreased appetite—Calcitriol—osteoporosis	0.000609	0.00235	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Alendronate—osteoporosis	0.000606	0.00233	CcSEcCtD
Magnesium salicylate—Oedema—Ethinyl Estradiol—osteoporosis	0.000605	0.00233	CcSEcCtD
Magnesium salicylate—Erythema—Conjugated Estrogens—osteoporosis	0.000604	0.00233	CcSEcCtD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—NFATC1—osteoporosis	0.000601	0.014	CbGpPWpGaD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A2—osteoporosis	0.0006	0.014	CbGpPWpGaD
Magnesium salicylate—Constipation—Calcitriol—osteoporosis	0.000599	0.00231	CcSEcCtD
Magnesium salicylate—Pain—Calcitriol—osteoporosis	0.000599	0.00231	CcSEcCtD
Magnesium salicylate—Urticaria—Estropipate—osteoporosis	0.000593	0.00229	CcSEcCtD
Magnesium salicylate—Dysgeusia—Conjugated Estrogens—osteoporosis	0.000592	0.00228	CcSEcCtD
Magnesium salicylate—Diarrhoea—Etidronic acid—osteoporosis	0.00059	0.00228	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Ibandronate—osteoporosis	0.00059	0.00227	CcSEcCtD
Magnesium salicylate—Urticaria—Alendronate—osteoporosis	0.000584	0.00225	CcSEcCtD
Magnesium salicylate—Epistaxis—Estradiol—osteoporosis	0.000584	0.00225	CcSEcCtD
Magnesium salicylate—Shock—Risedronate—osteoporosis	0.00058	0.00224	CcSEcCtD
Magnesium salicylate—Urticaria—Ibandronate—osteoporosis	0.000568	0.00219	CcSEcCtD
Magnesium salicylate—Confusional state—Pamidronate—osteoporosis	0.000565	0.00218	CcSEcCtD
Magnesium salicylate—Oedema—Pamidronate—osteoporosis	0.000561	0.00216	CcSEcCtD
Magnesium salicylate—Urticaria—Calcitriol—osteoporosis	0.000556	0.00215	CcSEcCtD
Magnesium salicylate—Hepatitis—Estradiol—osteoporosis	0.000555	0.00214	CcSEcCtD
Magnesium salicylate—Shock—Pamidronate—osteoporosis	0.000551	0.00213	CcSEcCtD
Magnesium salicylate—Vomiting—Etidronic acid—osteoporosis	0.000548	0.00211	CcSEcCtD
Magnesium salicylate—Rash—Etidronic acid—osteoporosis	0.000544	0.0021	CcSEcCtD
Magnesium salicylate—Dermatitis—Etidronic acid—osteoporosis	0.000543	0.00209	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Pamidronate—osteoporosis	0.000542	0.00209	CcSEcCtD
Magnesium salicylate—Headache—Etidronic acid—osteoporosis	0.00054	0.00208	CcSEcCtD
Magnesium salicylate—Anorexia—Pamidronate—osteoporosis	0.000534	0.00206	CcSEcCtD
Magnesium salicylate—Pruritus—Estropipate—osteoporosis	0.000528	0.00204	CcSEcCtD
Magnesium salicylate—Erythema multiforme—Estradiol—osteoporosis	0.000525	0.00202	CcSEcCtD
Magnesium salicylate—Hypotension—Pamidronate—osteoporosis	0.000524	0.00202	CcSEcCtD
Magnesium salicylate—ALB—Lipid and lipoprotein metabolism—P4HB—osteoporosis	0.000522	0.0122	CbGpPWpGaD
Magnesium salicylate—Pruritus—Alendronate—osteoporosis	0.00052	0.002	CcSEcCtD
Magnesium salicylate—Dyspepsia—Risedronate—osteoporosis	0.000519	0.002	CcSEcCtD
Magnesium salicylate—Tinnitus—Estradiol—osteoporosis	0.000518	0.002	CcSEcCtD
Magnesium salicylate—Constipation—Ethinyl Estradiol—osteoporosis	0.000517	0.00199	CcSEcCtD
Magnesium salicylate—Confusional state—Zoledronate—osteoporosis	0.000516	0.00199	CcSEcCtD
Magnesium salicylate—Flushing—Estradiol—osteoporosis	0.000515	0.00199	CcSEcCtD
Magnesium salicylate—Nausea—Etidronic acid—osteoporosis	0.000512	0.00198	CcSEcCtD
Magnesium salicylate—Oedema—Zoledronate—osteoporosis	0.000512	0.00197	CcSEcCtD
Magnesium salicylate—Diarrhoea—Estropipate—osteoporosis	0.000511	0.00197	CcSEcCtD
Magnesium salicylate—Pruritus—Ibandronate—osteoporosis	0.000506	0.00195	CcSEcCtD
Magnesium salicylate—Pain—Risedronate—osteoporosis	0.000504	0.00194	CcSEcCtD
Magnesium salicylate—Constipation—Risedronate—osteoporosis	0.000504	0.00194	CcSEcCtD
Magnesium salicylate—Shock—Zoledronate—osteoporosis	0.000504	0.00194	CcSEcCtD
Magnesium salicylate—Diarrhoea—Alendronate—osteoporosis	0.000503	0.00194	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000498	0.00192	CcSEcCtD
Magnesium salicylate—Somnolence—Pamidronate—osteoporosis	0.000498	0.00192	CcSEcCtD
Magnesium salicylate—Pruritus—Calcitriol—osteoporosis	0.000496	0.00191	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Zoledronate—osteoporosis	0.000495	0.00191	CcSEcCtD
Magnesium salicylate—Diarrhoea—Raloxifene—osteoporosis	0.000495	0.00191	CcSEcCtD
Magnesium salicylate—Dyspepsia—Pamidronate—osteoporosis	0.000493	0.0019	CcSEcCtD
Magnesium salicylate—Dizziness—Estropipate—osteoporosis	0.000493	0.0019	CcSEcCtD
Magnesium salicylate—Oedema—Conjugated Estrogens—osteoporosis	0.000493	0.0019	CcSEcCtD
Magnesium salicylate—Diarrhoea—Ibandronate—osteoporosis	0.00049	0.00189	CcSEcCtD
Magnesium salicylate—Anorexia—Zoledronate—osteoporosis	0.000488	0.00188	CcSEcCtD
Magnesium salicylate—Decreased appetite—Pamidronate—osteoporosis	0.000487	0.00188	CcSEcCtD
Magnesium salicylate—Dizziness—Alendronate—osteoporosis	0.000486	0.00187	CcSEcCtD
Magnesium salicylate—Shock—Conjugated Estrogens—osteoporosis	0.000485	0.00187	CcSEcCtD
Magnesium salicylate—Erythema—Estradiol—osteoporosis	0.000483	0.00186	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—PLEK—osteoporosis	0.000482	0.0112	CbGpPWpGaD
Magnesium salicylate—Urticaria—Ethinyl Estradiol—osteoporosis	0.00048	0.00185	CcSEcCtD
Magnesium salicylate—Constipation—Pamidronate—osteoporosis	0.000479	0.00185	CcSEcCtD
Magnesium salicylate—Pain—Pamidronate—osteoporosis	0.000479	0.00185	CcSEcCtD
Magnesium salicylate—Diarrhoea—Calcitriol—osteoporosis	0.000479	0.00185	CcSEcCtD
Magnesium salicylate—Hypotension—Zoledronate—osteoporosis	0.000478	0.00184	CcSEcCtD
Magnesium salicylate—Dizziness—Raloxifene—osteoporosis	0.000478	0.00184	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000477	0.00184	CcSEcCtD
Magnesium salicylate—Vomiting—Estropipate—osteoporosis	0.000474	0.00183	CcSEcCtD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—ACP5—osteoporosis	0.000474	0.011	CbGpPWpGaD
Magnesium salicylate—Dysgeusia—Estradiol—osteoporosis	0.000473	0.00183	CcSEcCtD
Magnesium salicylate—Dizziness—Ibandronate—osteoporosis	0.000473	0.00182	CcSEcCtD
Magnesium salicylate—Rash—Estropipate—osteoporosis	0.00047	0.00181	CcSEcCtD
Magnesium salicylate—Dermatitis—Estropipate—osteoporosis	0.00047	0.00181	CcSEcCtD
Magnesium salicylate—Anorexia—Conjugated Estrogens—osteoporosis	0.00047	0.00181	CcSEcCtD
Magnesium salicylate—Urticaria—Risedronate—osteoporosis	0.000468	0.00181	CcSEcCtD
Magnesium salicylate—Headache—Estropipate—osteoporosis	0.000467	0.0018	CcSEcCtD
Magnesium salicylate—Vomiting—Alendronate—osteoporosis	0.000467	0.0018	CcSEcCtD
Magnesium salicylate—Rash—Alendronate—osteoporosis	0.000463	0.00179	CcSEcCtD
Magnesium salicylate—Dermatitis—Alendronate—osteoporosis	0.000463	0.00178	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Pamidronate—osteoporosis	0.000462	0.00178	CcSEcCtD
Magnesium salicylate—ALB—Binding and Uptake of Ligands by Scavenger Receptors—COL1A1—osteoporosis	0.000461	0.0108	CbGpPWpGaD
Magnesium salicylate—Hypotension—Conjugated Estrogens—osteoporosis	0.000461	0.00178	CcSEcCtD
Magnesium salicylate—Headache—Alendronate—osteoporosis	0.00046	0.00177	CcSEcCtD
Magnesium salicylate—Vomiting—Raloxifene—osteoporosis	0.00046	0.00177	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—osteoporosis	0.000459	0.0107	CbGpPWpGaD
Magnesium salicylate—Rash—Raloxifene—osteoporosis	0.000456	0.00176	CcSEcCtD
Magnesium salicylate—Dermatitis—Raloxifene—osteoporosis	0.000455	0.00176	CcSEcCtD
Magnesium salicylate—Somnolence—Zoledronate—osteoporosis	0.000455	0.00175	CcSEcCtD
Magnesium salicylate—Vomiting—Ibandronate—osteoporosis	0.000455	0.00175	CcSEcCtD
Magnesium salicylate—Headache—Raloxifene—osteoporosis	0.000453	0.00175	CcSEcCtD
Magnesium salicylate—Rash—Ibandronate—osteoporosis	0.000451	0.00174	CcSEcCtD
Magnesium salicylate—Dermatitis—Ibandronate—osteoporosis	0.000451	0.00174	CcSEcCtD
Magnesium salicylate—Dyspepsia—Zoledronate—osteoporosis	0.000451	0.00174	CcSEcCtD
Magnesium salicylate—Headache—Ibandronate—osteoporosis	0.000448	0.00173	CcSEcCtD
Magnesium salicylate—Vomiting—Calcitriol—osteoporosis	0.000445	0.00172	CcSEcCtD
Magnesium salicylate—Decreased appetite—Zoledronate—osteoporosis	0.000445	0.00172	CcSEcCtD
Magnesium salicylate—Nausea—Estropipate—osteoporosis	0.000443	0.00171	CcSEcCtD
Magnesium salicylate—Rash—Calcitriol—osteoporosis	0.000442	0.0017	CcSEcCtD
Magnesium salicylate—Dermatitis—Calcitriol—osteoporosis	0.000441	0.0017	CcSEcCtD
Magnesium salicylate—Headache—Calcitriol—osteoporosis	0.000439	0.00169	CcSEcCtD
Magnesium salicylate—Somnolence—Conjugated Estrogens—osteoporosis	0.000438	0.00169	CcSEcCtD
Magnesium salicylate—Constipation—Zoledronate—osteoporosis	0.000438	0.00169	CcSEcCtD
Magnesium salicylate—Pain—Zoledronate—osteoporosis	0.000438	0.00169	CcSEcCtD
Magnesium salicylate—Nausea—Alendronate—osteoporosis	0.000437	0.00168	CcSEcCtD
Magnesium salicylate—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000434	0.00167	CcSEcCtD
Magnesium salicylate—Nausea—Raloxifene—osteoporosis	0.000429	0.00166	CcSEcCtD
Magnesium salicylate—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000429	0.00165	CcSEcCtD
Magnesium salicylate—Pruritus—Ethinyl Estradiol—osteoporosis	0.000428	0.00165	CcSEcCtD
Magnesium salicylate—Nausea—Ibandronate—osteoporosis	0.000425	0.00164	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Zoledronate—osteoporosis	0.000422	0.00163	CcSEcCtD
Magnesium salicylate—Pain—Conjugated Estrogens—osteoporosis	0.000422	0.00163	CcSEcCtD
Magnesium salicylate—Constipation—Conjugated Estrogens—osteoporosis	0.000422	0.00163	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—COL1A2—osteoporosis	0.000418	0.00975	CbGpPWpGaD
Magnesium salicylate—Pruritus—Risedronate—osteoporosis	0.000417	0.00161	CcSEcCtD
Magnesium salicylate—Nausea—Calcitriol—osteoporosis	0.000416	0.0016	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—TLN1—osteoporosis	0.000415	0.00969	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.000414	0.0016	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—VCL—osteoporosis	0.00041	0.00956	CbGpPWpGaD
Magnesium salicylate—PTGS1—Arachidonic acid metabolism—GPX1—osteoporosis	0.000409	0.00953	CbGpPWpGaD
Magnesium salicylate—Urticaria—Zoledronate—osteoporosis	0.000407	0.00157	CcSEcCtD
Magnesium salicylate—Diarrhoea—Risedronate—osteoporosis	0.000403	0.00156	CcSEcCtD
Magnesium salicylate—Dizziness—Ethinyl Estradiol—osteoporosis	0.0004	0.00154	CcSEcCtD
Magnesium salicylate—Confusional state—Estradiol—osteoporosis	0.000398	0.00153	CcSEcCtD
Magnesium salicylate—Pruritus—Pamidronate—osteoporosis	0.000397	0.00153	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TLN1—osteoporosis	0.000396	0.00923	CbGpPWpGaD
Magnesium salicylate—Oedema—Estradiol—osteoporosis	0.000395	0.00152	CcSEcCtD
Magnesium salicylate—Urticaria—Conjugated Estrogens—osteoporosis	0.000392	0.00151	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—VCL—osteoporosis	0.00039	0.00911	CbGpPWpGaD
Magnesium salicylate—Dizziness—Risedronate—osteoporosis	0.00039	0.0015	CcSEcCtD
Magnesium salicylate—Shock—Estradiol—osteoporosis	0.000388	0.0015	CcSEcCtD
Magnesium salicylate—Vomiting—Ethinyl Estradiol—osteoporosis	0.000385	0.00148	CcSEcCtD
Magnesium salicylate—Diarrhoea—Pamidronate—osteoporosis	0.000384	0.00148	CcSEcCtD
Magnesium salicylate—Hyperhidrosis—Estradiol—osteoporosis	0.000381	0.00147	CcSEcCtD
Magnesium salicylate—Rash—Ethinyl Estradiol—osteoporosis	0.000381	0.00147	CcSEcCtD
Magnesium salicylate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000381	0.00147	CcSEcCtD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—WNT1—osteoporosis	0.00038	0.00885	CbGpPWpGaD
Magnesium salicylate—Headache—Ethinyl Estradiol—osteoporosis	0.000379	0.00146	CcSEcCtD
Magnesium salicylate—Vomiting—Risedronate—osteoporosis	0.000375	0.00145	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—WDR1—osteoporosis	0.000372	0.00868	CbGpPWpGaD
Magnesium salicylate—Rash—Risedronate—osteoporosis	0.000372	0.00143	CcSEcCtD
Magnesium salicylate—Dermatitis—Risedronate—osteoporosis	0.000371	0.00143	CcSEcCtD
Magnesium salicylate—Dizziness—Pamidronate—osteoporosis	0.000371	0.00143	CcSEcCtD
Magnesium salicylate—Headache—Risedronate—osteoporosis	0.000369	0.00142	CcSEcCtD
Magnesium salicylate—Pruritus—Zoledronate—osteoporosis	0.000362	0.0014	CcSEcCtD
Magnesium salicylate—Nausea—Ethinyl Estradiol—osteoporosis	0.000359	0.00138	CcSEcCtD
Magnesium salicylate—Vomiting—Pamidronate—osteoporosis	0.000356	0.00137	CcSEcCtD
Magnesium salicylate—PTGS1—Biological oxidations—CYP27A1—osteoporosis	0.000356	0.00829	CbGpPWpGaD
Magnesium salicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—ESR1—osteoporosis	0.000354	0.00826	CbGpPWpGaD
Magnesium salicylate—Rash—Pamidronate—osteoporosis	0.000353	0.00136	CcSEcCtD
Magnesium salicylate—Dermatitis—Pamidronate—osteoporosis	0.000353	0.00136	CcSEcCtD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—TNF—osteoporosis	0.000352	0.00822	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	0.000352	0.0082	CbGpPWpGaD
Magnesium salicylate—Headache—Pamidronate—osteoporosis	0.000351	0.00135	CcSEcCtD
Magnesium salicylate—Somnolence—Estradiol—osteoporosis	0.000351	0.00135	CcSEcCtD
Magnesium salicylate—Diarrhoea—Zoledronate—osteoporosis	0.00035	0.00135	CcSEcCtD
Magnesium salicylate—Nausea—Risedronate—osteoporosis	0.00035	0.00135	CcSEcCtD
Magnesium salicylate—Pruritus—Conjugated Estrogens—osteoporosis	0.000349	0.00134	CcSEcCtD
Magnesium salicylate—Dyspepsia—Estradiol—osteoporosis	0.000347	0.00134	CcSEcCtD
Magnesium salicylate—Decreased appetite—Estradiol—osteoporosis	0.000343	0.00132	CcSEcCtD
Magnesium salicylate—Dizziness—Zoledronate—osteoporosis	0.000339	0.00131	CcSEcCtD
Magnesium salicylate—Pain—Estradiol—osteoporosis	0.000337	0.0013	CcSEcCtD
Magnesium salicylate—Constipation—Estradiol—osteoporosis	0.000337	0.0013	CcSEcCtD
Magnesium salicylate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000337	0.0013	CcSEcCtD
Magnesium salicylate—Nausea—Pamidronate—osteoporosis	0.000333	0.00128	CcSEcCtD
Magnesium salicylate—Dizziness—Conjugated Estrogens—osteoporosis	0.000326	0.00126	CcSEcCtD
Magnesium salicylate—Vomiting—Zoledronate—osteoporosis	0.000326	0.00126	CcSEcCtD
Magnesium salicylate—Feeling abnormal—Estradiol—osteoporosis	0.000325	0.00125	CcSEcCtD
Magnesium salicylate—PTGS2—Arachidonic acid metabolism—GPX1—osteoporosis	0.000324	0.00757	CbGpPWpGaD
Magnesium salicylate—Rash—Zoledronate—osteoporosis	0.000323	0.00124	CcSEcCtD
Magnesium salicylate—Dermatitis—Zoledronate—osteoporosis	0.000323	0.00124	CcSEcCtD
Magnesium salicylate—Headache—Zoledronate—osteoporosis	0.000321	0.00124	CcSEcCtD
Magnesium salicylate—Vomiting—Conjugated Estrogens—osteoporosis	0.000313	0.00121	CcSEcCtD
Magnesium salicylate—Urticaria—Estradiol—osteoporosis	0.000313	0.00121	CcSEcCtD
Magnesium salicylate—Rash—Conjugated Estrogens—osteoporosis	0.000311	0.0012	CcSEcCtD
Magnesium salicylate—ALB—Platelet degranulation—FGA—osteoporosis	0.000311	0.00724	CbGpPWpGaD
Magnesium salicylate—Dermatitis—Conjugated Estrogens—osteoporosis	0.000311	0.0012	CcSEcCtD
Magnesium salicylate—Headache—Conjugated Estrogens—osteoporosis	0.000309	0.00119	CcSEcCtD
Magnesium salicylate—Nausea—Zoledronate—osteoporosis	0.000304	0.00117	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—FGA—osteoporosis	0.000296	0.0069	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—CAP1—osteoporosis	0.000294	0.00686	CbGpPWpGaD
Magnesium salicylate—Nausea—Conjugated Estrogens—osteoporosis	0.000293	0.00113	CcSEcCtD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	0.000284	0.00664	CbGpPWpGaD
Magnesium salicylate—PTGS1—Overview of nanoparticle effects—IL6—osteoporosis	0.000284	0.00663	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—FGB—osteoporosis	0.000283	0.00659	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—TNF—osteoporosis	0.00028	0.00652	CbGpPWpGaD
Magnesium salicylate—Pruritus—Estradiol—osteoporosis	0.000279	0.00108	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—SOD2—osteoporosis	0.000273	0.00636	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—SOD2—osteoporosis	0.000271	0.00632	CbGpPWpGaD
Magnesium salicylate—Diarrhoea—Estradiol—osteoporosis	0.00027	0.00104	CcSEcCtD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—FGB—osteoporosis	0.000269	0.00628	CbGpPWpGaD
Magnesium salicylate—Dizziness—Estradiol—osteoporosis	0.000261	0.00101	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—GPX1—osteoporosis	0.00026	0.00606	CbGpPWpGaD
Magnesium salicylate—Vomiting—Estradiol—osteoporosis	0.000251	0.000967	CcSEcCtD
Magnesium salicylate—Rash—Estradiol—osteoporosis	0.000249	0.000959	CcSEcCtD
Magnesium salicylate—Dermatitis—Estradiol—osteoporosis	0.000249	0.000958	CcSEcCtD
Magnesium salicylate—Headache—Estradiol—osteoporosis	0.000247	0.000953	CcSEcCtD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00024	0.0056	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—MTHFR—osteoporosis	0.000238	0.00556	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000238	0.00555	CbGpPWpGaD
Magnesium salicylate—Nausea—Estradiol—osteoporosis	0.000234	0.000904	CcSEcCtD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—MGLL—osteoporosis	0.000234	0.00545	CbGpPWpGaD
Magnesium salicylate—PTGS2—Overview of nanoparticle effects—IL6—osteoporosis	0.000226	0.00526	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000225	0.00526	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—SOD2—osteoporosis	0.00022	0.00514	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—SOD2—osteoporosis	0.000216	0.00505	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—PLEK—osteoporosis	0.000214	0.00499	CbGpPWpGaD
Magnesium salicylate—PTGS1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	0.000211	0.00493	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	0.000211	0.00492	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—GPX1—osteoporosis	0.00021	0.0049	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—GPX1—osteoporosis	0.000206	0.00481	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—MTHFR—osteoporosis	0.000194	0.00452	CbGpPWpGaD
Magnesium salicylate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—osteoporosis	0.000192	0.00448	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—WDR1—osteoporosis	0.000192	0.00448	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—MTHFR—osteoporosis	0.00019	0.00444	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000189	0.0044	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—CYP19A1—osteoporosis	0.000187	0.00436	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	0.000184	0.0043	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	0.000182	0.00424	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000179	0.00417	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000175	0.00409	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	0.000175	0.00408	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000171	0.00398	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	0.000167	0.00389	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	0.000154	0.00359	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	0.000153	0.00356	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	0.000152	0.00354	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—CAP1—osteoporosis	0.000152	0.00354	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	0.00015	0.0035	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000148	0.00345	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	0.000145	0.00338	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000142	0.00332	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	0.000142	0.0033	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.00014	0.00327	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000139	0.00325	CbGpPWpGaD
Magnesium salicylate—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000138	0.00321	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	0.000138	0.00321	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000137	0.00318	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000136	0.00316	CbGpPWpGaD
Magnesium salicylate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000129	0.00301	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—IGF1—osteoporosis	0.000128	0.00298	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	0.000125	0.00292	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	0.000122	0.00284	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—MGLL—osteoporosis	0.000121	0.00281	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000116	0.00271	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL1B—osteoporosis	0.000115	0.00269	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000113	0.00264	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000113	0.00263	CbGpPWpGaD
Magnesium salicylate—PTGS1—Biological oxidations—POMC—osteoporosis	0.000112	0.00262	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—ANXA2—osteoporosis	0.00011	0.00257	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—PLEK—osteoporosis	0.00011	0.00257	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.00011	0.00256	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000108	0.00253	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PKM—osteoporosis	0.000106	0.00247	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—FDPS—osteoporosis	0.000106	0.00247	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.000103	0.00241	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	0.000103	0.00239	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPD2—osteoporosis	0.0001	0.00234	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PGLS—osteoporosis	0.0001	0.00234	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PKM—osteoporosis	0.0001	0.00234	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—SOST—osteoporosis	0.0001	0.00234	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	9.54e-05	0.00223	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PGLS—osteoporosis	9.51e-05	0.00222	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ANTXR2—osteoporosis	9.51e-05	0.00222	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TLN1—osteoporosis	9.5e-05	0.00222	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—VCL—osteoporosis	9.37e-05	0.00219	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	9.22e-05	0.00215	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PNP—osteoporosis	9.18e-05	0.00214	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ATIC—osteoporosis	9.18e-05	0.00214	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	9.15e-05	0.00213	CbGpPWpGaD
Magnesium salicylate—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	9.14e-05	0.00213	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	9.11e-05	0.00212	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	8.94e-05	0.00209	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	8.77e-05	0.00205	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—FDPS—osteoporosis	8.41e-05	0.00196	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PKM—osteoporosis	8.41e-05	0.00196	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—TNF—osteoporosis	8.35e-05	0.00195	CbGpPWpGaD
Magnesium salicylate—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	8.34e-05	0.00194	CbGpPWpGaD
Magnesium salicylate—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	8.29e-05	0.00193	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	8.2e-05	0.00191	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GSN—osteoporosis	8.09e-05	0.00189	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PGLS—osteoporosis	7.97e-05	0.00186	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPD2—osteoporosis	7.97e-05	0.00186	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	7.88e-05	0.00184	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—RAP1A—osteoporosis	7.83e-05	0.00183	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—OXCT1—osteoporosis	7.81e-05	0.00182	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CA2—osteoporosis	7.81e-05	0.00182	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet degranulation—TGFB1—osteoporosis	7.67e-05	0.00179	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MGLL—osteoporosis	7.61e-05	0.00177	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	7.46e-05	0.00174	CbGpPWpGaD
Magnesium salicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	7.31e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PNP—osteoporosis	7.29e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ATIC—osteoporosis	7.29e-05	0.0017	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	7.17e-05	0.00167	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FGA—osteoporosis	7.1e-05	0.00166	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LRP5—osteoporosis	7.04e-05	0.00164	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—MYC—osteoporosis	6.96e-05	0.00162	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	6.95e-05	0.00162	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—FDPS—osteoporosis	6.8e-05	0.00159	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PKM—osteoporosis	6.8e-05	0.00159	CbGpPWpGaD
Magnesium salicylate—ALB—Folate Metabolism—IL6—osteoporosis	6.74e-05	0.00157	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LRP6—osteoporosis	6.73e-05	0.00157	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—TNF—osteoporosis	6.64e-05	0.00155	CbGpPWpGaD
Magnesium salicylate—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	6.62e-05	0.00154	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—TNF—osteoporosis	6.49e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—IDH2—osteoporosis	6.47e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—LTF—osteoporosis	6.47e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—RPL24—osteoporosis	6.47e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—FGB—osteoporosis	6.46e-05	0.00151	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPD2—osteoporosis	6.45e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PGLS—osteoporosis	6.45e-05	0.0015	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—OXCT1—osteoporosis	6.2e-05	0.00145	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CA2—osteoporosis	6.2e-05	0.00145	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP27A1—osteoporosis	6.08e-05	0.00142	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MGLL—osteoporosis	6.04e-05	0.00141	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ACP5—osteoporosis	5.92e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ATIC—osteoporosis	5.9e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PNP—osteoporosis	5.9e-05	0.00138	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.84e-05	0.00136	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	5.69e-05	0.00133	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	5.68e-05	0.00132	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ACP5—osteoporosis	5.61e-05	0.00131	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—TPI1—osteoporosis	5.5e-05	0.00128	CbGpPWpGaD
Magnesium salicylate—ALB—Selenium Micronutrient Network—IL6—osteoporosis	5.36e-05	0.00125	CbGpPWpGaD
Magnesium salicylate—PTGS2—Spinal Cord Injury—IL6—osteoporosis	5.24e-05	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TPI1—osteoporosis	5.21e-05	0.00122	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—P4HB—osteoporosis	5.17e-05	0.00121	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—IDH2—osteoporosis	5.13e-05	0.0012	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GAPDH—osteoporosis	5.08e-05	0.00118	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CA2—osteoporosis	5.01e-05	0.00117	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—OXCT1—osteoporosis	5.01e-05	0.00117	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—RAP1A—osteoporosis	4.94e-05	0.00115	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—P4HB—osteoporosis	4.9e-05	0.00114	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MGLL—osteoporosis	4.89e-05	0.00114	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP27A1—osteoporosis	4.83e-05	0.00113	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—GAPDH—osteoporosis	4.81e-05	0.00112	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	4.74e-05	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	4.73e-05	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ACP5—osteoporosis	4.7e-05	0.0011	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	4.64e-05	0.00108	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	4.61e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—NFATC1—osteoporosis	4.57e-05	0.00107	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—DKK1—osteoporosis	4.54e-05	0.00106	CbGpPWpGaD
Magnesium salicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	4.41e-05	0.00103	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—WNT1—osteoporosis	4.37e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—TPI1—osteoporosis	4.37e-05	0.00102	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	4.31e-05	0.00101	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—FGA—osteoporosis	4.25e-05	0.000991	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—IDH2—osteoporosis	4.15e-05	0.000969	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—P4HB—osteoporosis	4.1e-05	0.000957	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GAPDH—osteoporosis	4.03e-05	0.00094	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ENO1—osteoporosis	4e-05	0.000932	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSMA2—osteoporosis	3.94e-05	0.000918	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—PSMA5—osteoporosis	3.94e-05	0.000918	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—RAP1A—osteoporosis	3.92e-05	0.000915	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP27A1—osteoporosis	3.91e-05	0.000911	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ACP5—osteoporosis	3.8e-05	0.000886	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ENO1—osteoporosis	3.79e-05	0.000883	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	3.75e-05	0.000875	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSMA2—osteoporosis	3.73e-05	0.000871	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—PSMA5—osteoporosis	3.73e-05	0.000871	CbGpPWpGaD
Magnesium salicylate—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	3.58e-05	0.000835	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—TPI1—osteoporosis	3.53e-05	0.000824	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—CALCA—osteoporosis	3.48e-05	0.000811	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.42e-05	0.000798	CbGpPWpGaD
Magnesium salicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	3.4e-05	0.000794	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—P4HB—osteoporosis	3.32e-05	0.000775	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GAPDH—osteoporosis	3.26e-05	0.00076	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—CYP19A1—osteoporosis	3.19e-05	0.000745	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—RAP1A—osteoporosis	3.17e-05	0.000741	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ENO1—osteoporosis	3.17e-05	0.00074	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—KL—osteoporosis	3.16e-05	0.000737	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSMA5—osteoporosis	3.13e-05	0.000729	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—PSMA2—osteoporosis	3.13e-05	0.000729	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—IGF1—osteoporosis	2.93e-05	0.000682	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	2.77e-05	0.000646	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—ADCY5—osteoporosis	2.61e-05	0.000609	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—GPX1—osteoporosis	2.6e-05	0.000607	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ENO1—osteoporosis	2.57e-05	0.000599	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—CYP19A1—osteoporosis	2.54e-05	0.000591	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSMA5—osteoporosis	2.53e-05	0.00059	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—PSMA2—osteoporosis	2.53e-05	0.00059	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—ADCY5—osteoporosis	2.47e-05	0.000577	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—MTHFR—osteoporosis	2.4e-05	0.00056	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MTHFR—osteoporosis	2.28e-05	0.000531	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IRS2—osteoporosis	2.16e-05	0.000505	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—ADCY5—osteoporosis	2.07e-05	0.000483	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—GPX1—osteoporosis	2.06e-05	0.000482	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—CYP19A1—osteoporosis	2.05e-05	0.000479	CbGpPWpGaD
Magnesium salicylate—PTGS1—Metabolism—POMC—osteoporosis	1.92e-05	0.000448	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—MTHFR—osteoporosis	1.91e-05	0.000444	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IRS1—osteoporosis	1.89e-05	0.000441	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6R—osteoporosis	1.78e-05	0.000414	CbGpPWpGaD
Magnesium salicylate—ALB—Hemostasis—TGFB1—osteoporosis	1.75e-05	0.000409	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—ADCY5—osteoporosis	1.68e-05	0.000391	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—GPX1—osteoporosis	1.67e-05	0.00039	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—MTHFR—osteoporosis	1.54e-05	0.00036	CbGpPWpGaD
Magnesium salicylate—PTGS2—Metabolism—POMC—osteoporosis	1.52e-05	0.000355	CbGpPWpGaD
Magnesium salicylate—ALB—Metabolism—POMC—osteoporosis	1.23e-05	0.000288	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—MYC—osteoporosis	1.05e-05	0.000245	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—TGFB1—osteoporosis	1.05e-05	0.000245	CbGpPWpGaD
Magnesium salicylate—PTGS2—Disease—IL6—osteoporosis	7.91e-06	0.000184	CbGpPWpGaD
